Germed Pharma   Report issue

For profit Phase 2
Founded: Cinisello Balsamo Italy (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2009
NCT01414465
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

isotretinoin (accutane) (1 trial)

tretinoin (Retin-A) (1 trial)

Drugs in Other Trials (1)

orlistat (xenical) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3